AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Gentian Diagnostics AS

NOK 38.30 -$18.90 (-33.04%)
OSL · 30 Oct 2026 12:30 UTC
Previous Close
NOK 38.60
Day Range
NOK 38.20NOK 39.40
Year Range
NOK 33.50NOK 60.00
Market Cap
592.07M
AVG Volume
3.69K
Trailing/Forward PE
-116.06/14.73
PEG ratio
-1.37
Dividend Yield
1.57%
Next Earnings Date
2027-02-18
Primary Exchange
Oslo Stock ExchangeNO
Revenue (NOK) · TTM
050M100M150M200M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
GENT.OL Revenue (NOK) by quarter, trailing twelve months
PeriodRevenue (NOK)
26 Q3191.35M
26 Q2182.12M
26 Q1175.92M
25 Q4176.5M
25 Q3172.52M
25 Q2163.38M
25 Q1158.07M
24 Q4152.07M
24 Q3146.93M
24 Q2147.19M
Net Income (NOK) · TTM
-20M020M40M60M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
GENT.OL Net Income (NOK) by quarter, trailing twelve months
PeriodNet Income (NOK)
26 Q3-5.06M
26 Q2-8.41M
26 Q1-14.79M
25 Q413.26M
25 Q342.78M
25 Q242.19M
25 Q148.89M
24 Q445.29M
24 Q32.22M
24 Q2-2.01M
Operating Income (NOK) · TTM
-20M-10M010M20M30M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
GENT.OL Operating Income (NOK) by quarter, trailing twelve months
PeriodOperating Income (NOK)
26 Q3-4.29M
26 Q2-8.39M
26 Q1-14.85M
25 Q424.4M
25 Q322.14M
25 Q219.77M
25 Q123.88M
24 Q414.76M
24 Q35.13M
24 Q21.22M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (NOK) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: GENT.OL

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 18 Feb 2027.

Gentian Diagnostics AS
GENT.OL
Stockpicker

Video analysis: GENT.OL

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: GENT.OL

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.